Portfolio company
Brooklyn Health
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
2 investors
Sectors
About
This neuroscience technology company develops an artificial intelligence platform to provide objective mental health measurement for pharmaceutical companies conducting clinical trials.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
NeuraLight
The company develops an artificial intelligence platform measuring eye movements to create digital biomarkers for pharmaceutical companies and researchers treating neurological disorders.
Ceretype Neuromedicine
This company develops functional MRI and AI-powered biomarker platforms for pharmaceutical developers and clinicians to measure brain circuitry in psychiatric and neurological diseases.
Hemispheric
This company develops artificial intelligence models and platforms for decoding non-invasive brain signals to assist clinicians and researchers with neurological and psychiatric diagnoses.
Behavidence
This company develops a digital platform that uses passive smartphone monitoring to provide mental health metrics for clinicians, insurers and government agencies.
Alto Neuroscience
This biopharmaceutical company develops precision medicines for patients with neuropsychiatric conditions by using an artificial intelligence platform to analyse brain-based biomarkers.
Cogstate
This company provides digital cognitive assessments and clinical trial services for biopharmaceutical companies, academic researchers and healthcare providers to measure brain health.
HealthMode
This company develops an artificial intelligence platform for automated patient monitoring and digital measurement tools to support clinical researchers and drug developers.
BeCareLink
This company develops mobile applications using artificial intelligence to monitor and assess neurological functions for patients and healthcare providers.
